Almost $20 trillion in revenue—and a record-breaking $1.87 trillion in profits. Introducing the 2025 Fortune 500, the definitive list of the biggest companies in America.

Fortune 500

Leaders in all industries rely more than ever on Big Tech—and appreciate the giants that deliver, at scale, without drama.

World's Most Admired Companies

Industries included in the sector are beverages, food consumer products, and food production.

Fortune Sector Leaders: Food, Beverages, and Tobacco

The Fortune 500, in its 70th year in 2024, ranks the biggest U.S. companies by revenue.

The 26th edition of the list shows how much esteem Big Tech giants command among other business leaders.

The Fortune 500, in its 69th year in 2023, ranks the biggest U.S. companies by revenue.

Just as it dominates our economy, Big Tech now dominates Fortune’s annual ranking of corporate reputation.

This year’s Fortune 500 marks the 68th running of the list.

After a year in which humanity leaned more heavily than ever on tech giants, see which companies topped Fortune's ranking of corporate reputation.

This year’s Fortune 500 marks the 67th running of the list.

True to its name, the multinational company produces ingredients such as starch and high fructose syrup for use in the food, beverage, and pharmaceutical industries.

For an astounding 13th straight year, Apple claims the top spot in Fortune’s annual ranking of corporate reputation, based on a survey of almost 3,800 executives, directors, and analysts.

This year's Fortune 500 marks the 66th running of the list.

F500-2020-475-Ingredion

The Illinois-based ingredient company supplies companies in the food, beverage, brewing, and pharmaceutical industries.

Here are the World's Most Admired Companies for 2019 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 65th running of the list.

Here are the World's Most Admired Companies for 2018 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 64th running of the list.

Here are the World's Most Admired Companies for 2017 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 63rd running of the list.

Here are the World's Most Admired Companies for 2016 as ranked in their industries. See who made the list.

This year's Fortune 500 marks the 62nd running of the list.

Business insiders have spoken: Asked which companies they most admire, more than 4,100 executives, directors, and analysts chose these top 50 All-Stars.

This year's Fortune 500 marks the 61st running of the list. Wal-Mart claims the top spot again. See who made the list.

Wal-Mart stayed on top as its sales crept closer to half-a-trillion dollars. Apple moved into the top five. And UnitedHealth Group continued its steady climb. 

Sector

Industry

Current All-Star Rank

Previous All-Star Rank

Industry Rank

Previous Industry Rank

Overall Score

Innovation

People Management

Use of Corporate Assets

Social Responsibility

Quality of Management

Financial Soundness

Long-Term Investment Value

Quality of Products/Services

Global Competitiveness

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Earnings Per Share (last Fiscal Year)

Earnings Per Share ($)

EPS % Change (from prior fiscal year)

EPS % Change (5 year annual rate)

EPS % Change (10 year annual rate)

Total Return

Total Return to Investors (last year)

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

Q2 2025

Q1 2025

Q4 2024

Get insights into Ingredion including business profile, stock information, news, and rankings from Fortune.

Ingredion (INGR): Company Profile, Stock Price, News, Rankings

legacy

Ingredion

ingredion

Good day, and thank you for standing by. Welcome to the Ingridion's Fourth Quarter and Full Year twenty twenty four Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded.

I would now like to turn the call over to Noah's Weisz, Vice President of Investor Relations. Please go ahead.

Good morning, and welcome to Ingredion's fourth quarter and full year twenty twenty four earnings call. I'm Noah Weiss, Vice President of Investor Relations. Joining me on today's call are Jim Zalley, our President and CEO and Jim Gray, our Executive Vice President and CFO. The press release we issued today as well as the presentation will be we will reference for our and full year results can be found on our website, ingredion.com in the Investors section. As a reminder, our comments within this presentation may contain forward looking statements.

These statements are subject to various risks and uncertainties and include expectations and assumptions regarding the company's future operations and financial performance. Actual results could differ materially from those estimated in the forward looking statements and Ingredion assumes no obligation to update them in the future as or if circumstances change. Additional information concerning factors that could cause actual results to differ materially from those discussed during today's conference call or in this morning's press release can be found in the company's most recently filed annual report on Form 10 K and subsequent reports on Form 10 Q and eight K. During this call, we also refer to certain non GAAP financial measures, including adjusted earnings per share, adjusted operating income and adjusted effective tax rate, which are reconciled to U. S.

GAAP measures in Note two non GAAP information included in our press release and in today's presentation appendix. With that, I will turn the call over to Jim Zelle.

Thank you, Noah, and good morning, everyone. I am pleased to announce that Ingredion achieved significant double digit adjusted EPS growth for the This performance was driven by continued strong sales volume growth in Texture and Healthful Solutions, as well as exceptional performance from each of our Food and Industrial Ingredients segments. Our 2024 reorganization and new segment structure positioned our teams well against our targeted markets and customer opportunities, establishing a solid foundation for the future. Our Food and Industrial Ingredients U. S./Canada business benefited from the renewal of multi year contracts that enabled us to recapture inflationary impacts and recover margins resulting in significant operating income growth for the For Food and Industrial Ingredients LATAM, the Mexico and Andean businesses delivered strong results despite softer sweetener demand.

The strength and agility of our business model in the region enabled us to manage pricing in the face of changing corn costs and currency fluctuations. These factors collectively led to a year over year increase of 5% in operating income or an increase of 8% when adjusting for the sale of the South Korea business. Turning to a summary of our net sales volume growth for the quarter. Ingredion continued to drive organic growth with a 4% increase compared to last year when adjusted for the sale of our South Korea business. Beginning with Texture and Healthful Solutions, we experienced a double digit sales volume increase for the second consecutive quarter.

Food and beverage categories in The U. S. Such as yogurt, beverages and batters and breadings were key contributors to this growth. Despite ongoing food inflation impacting Western European markets, the categories most relevant to Ingredion in that region have consistently outperformed the overall market throughout 2024, especially in the latter half of the year. Sectors such as dressings, ready to eat and frozen meals and dairy products continue to demonstrate recovery as consumers traveled and returned to more in office work routines and placed an increased emphasis on value.

As mentioned during our Texture Innovation Day, we are continuing to drive volume growth with our most differentiated products and solutions, which generally offer higher profitability. In the Food and Industrial Ingredients LatAm segment, net sales volumes were down 4% in the quarter, mainly due to soft sweetener sales to the Mexican beverage market, in addition to sales to the Andean confectionery category also experienced softer demand. Lastly, in Food and Industrial U. S. Canada, strong demand from papermaking and packaging customers was partially offset by weaker sweetener shipments.

For the full year 2024, gross profit dollars and margins reached record levels of $180,000,000,0.0 with a corresponding margin of 24%, up two seventy basis points compared to 2023. Our operations and procurement teams have played a pivotal role in driving operational excellence across the organization. Their focus on optimizing capacity utilization, streamlining supply chain processes and implementing procurement led cost saving measures have increased efficiency and reduced costs. Let me now update you on our progress against our three strategic pillars. Beginning with business growth, in the quarter, our Texture and Healthful Solutions segment demonstrated robust performance with strong sales volume growth and expanding operating income margins.

We continue to progress our solutions selling approach focused on demonstrating the impact of Textural Solutions to improve taste and overall liking. Underpinning our solutions capabilities, we have invested in strengthening formulation expertise and improving the quality of customer briefs. We are focused on solving unique customer challenges by providing tailored solutions for health and wellness, clean label and affordability. We are continuing to invest in future innovation and revenue growth. Our Food and Industrial Ingredients U.

S. Can segment demonstrated significant operating income growth. We successfully adjusted multiyear contracts to recapture prior year's inflationary impacts and enable margin recovery. Further supporting this segment's performance was strong demand from the papermaking and packaging industries. Turning to the second strategic pillar, cost competitiveness through operational excellence.

We are pleased to report that at the end of the first year of our cost to compete program, we exceeded our year one run rate cost savings target of $18,000,000 by more than 30%. We will meet or exceed our run rate target of $50,000,000 by the and we'll provide an update to the program outlook later this year. A significant portion of the targeted cost of goods sold savings in 2025 will come from strategic network sourcing moves that enabled us to further optimize our asset footprint and close three of our smaller facilities, one each in The UK, Brazil and Canada. It is also noteworthy to mention that this morning, we announced $100,000,000 of investments to expand Ingredion's capabilities for delivering texture innovations to growing end markets while bolstering the economic viability and sustainability of the Indianapolis plant. Furthermore, by upgrading Indianapolis' energy infrastructure, Ingredion will improve operational efficiency and reliability while reducing greenhouse gas emissions.

Additionally, these investments will enable the Indianapolis plant to lead in supplying the highest quality and most innovative specialty starch based texturizers for global customers. Moving to our last pillar, our people centric performance growth culture. In Dec. 0, we were honored to be recognized for the first time ever by The Wall Street Journal as one of the two fifty best managed companies. This recognition demonstrated Ingredion's achievements in customer satisfaction, employee engagement, innovation and financial strength.

In addition, our dedication to fostering an inclusive work environment was further highlighted by Ingredion Brazil being designated as a great place to work for 2025. And finally, Ingredion was named a top employer in Singapore and Thailand for the fifth consecutive year while achieving that status in China, Germany, Malaysia and The United Kingdom for three consecutive years. There are also a number of notable achievements to highlight after the first year of our global reorganization, business re segmentation and cost to compete program. We advanced a customer centric approach to optimizing and de risking our supply chain by making selective investments and taking restructuring actions to enhance service and improve perfect order delivery. Re segmentation also increased business performance and visibility, providing a clearer view of segment demand drivers.

Global operations standardized roles and processes leveraging their global scale, which is just beginning to lead to better execution and improved efficiencies. Lastly, we made strategic investments for growth, progressing texture and helpful solutions capacity expansions in Thailand, The U. S. And Germany. Now, I am pleased to hand it over to Jim Gray for the financial review.

Thank you, Jim, and good morning, everyone. Moving to our income statement. Net sales for the were $180,000,000,0.0 down 6% versus prior year. Gross profit dollars grew 12% with corresponding margins up four twenty basis points to 25%. Reported and adjusted operating income were $162,000,000 and $2.48,000,000 dollars respectively with adjusted operating income up 22% versus the prior year driven by lower raw material costs, greater sales volume and fixed cost absorption, partially offset by price mix.

Turning to our net sales bridge, the 6% decrease was driven by $92,000,000 in lower price mix and $33,000,000 of foreign exchange impacts, partially offset by positive sales volume growth of $77,000,000 Furthermore, the exit from South Korea had a $73,000,000 impact on sales volume. Turning to the next slide, we highlight net sales drivers for the For the total company, net sales were down 6% and excluding the impact of South Korea sales from results, net sales were down 2%. Extra and Healthful Solutions net sales were up 1% driven by sales volume growth of positive 10%. Price mix declined 10% for the quarter, primarily reflecting the pass through of lower corn costs as well as lapping last year's higher pricing due to double digit inflation experienced in specialty corn and energy costs. Food and Industrial Ingredients LatAm net sales were down 9% and Food and Industrial Ingredients U.

S. Can net sales were down 2%. Both results impacted primarily from the pass through of lower corn costs. The trajectory of our Texturant Healthful Solutions business is demonstrating a full recovery from the demand impacts of industry destocking experienced in 2023. The operating income has steadily returned to more consistent levels throughout 2024, particularly in the latter half of the year, recognizing that Textures Solutions is not significantly impacted by seasonality.

This stable trend is expected to continue into 2025. Turning to our earnings bridge. On the top half, you can see the reconciliation from reported to adjusted earnings per share. Operationally, we saw an increase of $0,.52 per share for the quarter. The increase was driven primarily by an operating margin increase of $0,.67 partially offset by other income of minus $0.1 per share.

Moving to the change in non operational items, we had an increase of $0,.14 per share, primarily driven by lower financing costs of $0,.19 per share, partially offset by a higher tax rate equivalent to minus $0,.06 per share. Shifting to our year to date income statement highlights. Net sales for the full year were approximately $740,000,000,0.0 down 9% versus the prior year due mainly to lower corn costs. Gross profit dollars increased 2% and gross margin was up two seventy basis points to 24.1%. Reported and adjusted operating income were $8.83 dollars and $1,016,000,000 respectively with adjusted operating income up 5% from last year.

Turning to our full year net sales bridge, the 9% decrease was driven by $6.22,000,000 dollars of lower price mix and $52,000,000 of foreign exchange impacts, partially offset by positive sales volume growth of $2.27,000,000 dollars Furthermore, the exit from South Korea had a $2.83,000,000 dollars sales volume dollar impact. Turning to the next slide, we highlight net sales drivers for the full year. For the total company, net sales were down 9%. However, excluding the impact of South Korea sales from results, net sales were down 6%. Texture and Health Solutions net sales were down 4%, pricemix was down 10% and sales volume was up 7% for the full year.

Food and Industrial Ingredients LatAm net sales were down 7% and Food and Industrial Ingredients U. S./Canada net sales were down 8% for the full year, both results impacted by the pass through of lower corn costs. Let me turn to a full year summary of each segment's performance now that we have completed our first year reporting under new segmentation. For 2024, net sales were down 4% compared to the prior year and down 3% on a constant currency basis. Although Texture and Health Solutions operating income was down 11% from prior year, it is important to note the sequential profit improvement through each quarter in 2024 as we fully lap the impacts of industry destocking.

In Food and Industrial Ingredients LatAm, net sales were down 7% versus last year and down 6% on a constant currency basis. Operating income improved to $4.83,000,000 dollars resulting in 7% year over year growth. Off income margin of 19.7% was driven by strong results overall in Mexico and an improving year over year input cost structure in Brazil as our transition to biomass energy was completed. Moving to Food and Industrial Ingredients U. S.

Canada, full year net sales were down 8%. Operating income was $3.73,000,000 dollars up 25% with operating income margin improving to 17.3%. The exceptional increase in operating income was driven primarily by renewal of multiyear customer contracts, which reflect catch ups from prior year's higher inflation. The full year results also benefited from lower raw material costs, though partially offset by lower price mix. For All Other, the net sales decrease was driven by the overlap of South Korea's net sales included in the prior year.

All Other operating loss of minus $22,000,000 was driven primarily by the sale of our South Korea business, which had contributed $30,000,000 to the prior year's results. Turning to our year to date earnings bridge, the company delivered an increase of $1,.23 per share. Operationally, we saw an increase of $0,.52 per share. The increase was driven primarily by an operating margin increase of $1,.09 partially offset by volume of minus $0,.47 per share. Moving to the change in our non operational items, we had an increase of $0,.71 per share, primarily driven by lower financing costs of $0,.85 per share, partially offset by a higher tax rate equivalent to a negative $0,.24 Moving to cash flow, 2024 cash generated from operations was $140,000,000,0.0 Cash from operations benefited from consistent net income growth and an exceptional contribution from working capital change, which is typical when we experienced lower corn costs throughout the year.

We highlight here the change in working capital balances contributed almost $400,000,000 to our cash from operations. As we look forward to 2025, we anticipate flat to slightly higher corn costs and are expecting to invest in working capital. Full year 2024 capital expenditures net of disposals came in at $2.95,000,000 dollars As announced earlier, we will continue to invest in growth initiatives and have begun several one time but significant cost savings and infrastructure projects that will be completed by 2026. In the full year 2024, we repurchased over $200,000,000 of outstanding common shares, more than doubling our initial goal for share repurchases set at the beginning of the year. Our capital allocation priorities continue to be organic investment into our business, primarily focused on higher return growth opportunities.

And secondarily, being mindful of total return to shareholders through our dividend and share repurchases. We actively look at M and A to accelerate our strategic priorities and believe that we have a strong balance sheet to consider the best options for shareholder value creation. As outlined in our 2025 guidance, we will be raising our capital expenditures to an investment level of $400,000,000 to $4.50,000,000 dollars for $20.25,000,000 dollars This represents a one time step up from our historical capital investment range of $300,000,000 to $3.50,000,000 dollars 1 significant driver of this higher investment level is the opportunity to leverage incentives granted in the Inflation Reduction Act that will enhance our cost position and enable us to capture future efficiencies at our Indy plant. Now let me turn to our outlook for 2025. For the full year 2025, we anticipate continued sales volume growth and op income improvement.

We expect net sales for Ingredion to be up low single digits, reflecting greater volume demand, partially offset by price mix and foreign exchange. We anticipate that adjusted operating income will be up mid single digits. Our 2025 financing cost estimate is in the range of $50,000,000 to $70,000,000 to align with the reduction of overall debt levels and the anticipation of a stronger U. S. Dollar in our current foreign exchange outlook.

For the full year 2025, we expect reported and adjusted effective tax rates of 26% to 27.5%. For the full year, reported and adjusted EPS are expected to be in the range of $10,.75 to $11,.55 This guidance does not anticipate extraordinary changes in current tax rates, tariffs or trade or food regulations. Furthermore, our expectation excludes acquisition related integration and restructuring costs as well as any potential impairment costs. We expect diluted weighted average shares outstanding to be between 6,550,000,0.0 and 6,650,000,0.0 shares. We are once again establishing a share repurchase objective of at least $100,000,000 for 2025.

We anticipate our 2025 cash from operations to be in the range of $800,000,000 to $9.50,000,000 dollars Corporate costs are now expected to be up mid single digits to high single digits year over year, reflecting compensation increases and center led investments in R and D and digital IT capabilities. Turning to the segment detail for our 2025 outlook. For Texture and Healthful Solutions, we expect net sales to be up mid single digits and operating income to be up mid single digits to high single digits driven by sales volume growth. For Food and Industrial LatAm, we expect net sales to be flat and expect operating income to be up mid single digits. For Food and Industrial U.

S. Canada, we expect net sales to be down low single digits and operating income to be flat to down low single digits.

not a segment per se, is made up of various businesses with distinct business drivers. We expect net sales combined for the sum of these businesses to be up high single digits and operating income is anticipated to approach breakeven profitability. Lastly, for the we expect net sales to be down low single digits for the entire company and operating income to be up high single digits. That concludes my comments and I'll turn it back over to Jim.

Thanks, Jim. Our record performance in 2024 provides momentum heading into 2025. In addition to solid volume growth in Texture and Healthful Solutions and operational execution across our entire business, we also exceeded our first year cost to compete run rate savings target. Our exceptionally strong cash flow from operations bolstered by short term working capital benefits has enabled us to step up organic investments in 2025. Additionally, we returned $4.26,000,000 dollars to shareholders in 2024, demonstrating our commitment to shareholder value.

We anticipate further strengthening of customer collaborations to drive growth and continued cost to compete savings from the second year of initiatives to position us well to navigate a dynamic business environment in 2025. We will continue to allocate capital that prioritizes organic investment to drive future profit growth while returning capital through dividends and share repurchases to deliver shareholder value. Now let's open the call for questions. Operator?

Thank you. Our first question will be coming from the line of Christian Owen of Oppenheimer. Your line is open.

Good morning. Thank you for taking the question and congratulations on the nice results.

So understanding thanks, Jim. Understanding that you guys did come in ahead of expectations in 2024, But I'll say I was a little bit surprised by the 2025 EPS guidance.

The low end implies just about a percentage of growth, high end 8.5%. It's a pretty wide range of expectations there. Can you help us understand the swing factors? What will put the low end in play and what needs to happen to achieve the high end?

Yes. Kristen, normally when I think we're beginning of the year, we're going to look at a range that's relatively wide. I think early on, there's also always going to be like, well, which way is maybe the spring crop in The U. S. Kind of play out as well as right now, I think this year looking really at FX rate.

So I think on the low side of our earnings estimate, probably greater currency weakness could play into facts in Brazil, Colombia, Europe, maybe China. I'd say there's probably some offsets maybe in weakness in the Thai baht, which is generally a benefit from us. We're watching kind of softer co product values in Europe. We want to see how the French corn crop comes in. And then just generally slightly higher corn costs potentially always can be just a slight headwind even though we extensively hatch.

Our upsides are really driven by kind of greater than expected volume. I still believe that there's potentially even more volume, unit volume growth out there in a very low inflationary environment in food and beverage, right? So that tends to be pretty positive for ingredients suppliers. I think there's also kind of increased wins as we look at customer reformulations, particularly maybe given some of the dynamics in The U. S.

And then there's always some spot pricing opportunities. And so those are some of the flavor of the potential downsides, but also the upsides in our guidance range. Yes.

I think just to complement that, I think just at this point early in the year, with some of the dynamic elements that are in play, and I think you called out foreign exchange as one of the ones that we're watching closely. That all being said, we do a pretty good job managing that and have historically. But that's the reason at this point in the year, early in the year for a wider range. But obviously, we looked at what that conveys from a center cut standpoint and what we feel would be in line with say the long term profit outlook for the business.

Appreciate that color. And then if I could ask on the $100,000,000 CapEx investment in Indiana, You noted the step up in the free cash flow that enabled that to happen, but just how this fits into your capital allocation strategy as you're thinking specifically for 2025 and 2026? Would this impact your willingness to look at acquisition targets? How are you viewing the pipeline at this stage? And thoughts on the pace of share repurchases?

I think you mentioned $100,000,000 on the call. So just any context around that? Thank you.

Yes. Well, Kristen, I think when you finish a year like we just did in 2024 where we didn't have to invest in working capital. And just to remind you, we put a lot of investment into working capital in 2022. That has now really come back. And because we've managed cash well, I think we have a really strong balance sheet.

So when you sit back and you say, well, what are the best opportunities to go create shareholder value? And the team thought I thought very broadly about this. Jim challenged us all, not just in our segments, but also in our operations. And we said, well, wait a minute, there's some very good investment opportunities for us. And it wants continuing to invest in organic growth where we have capacity where we need it generally in other places around the world.

But when we looked at Indy, there was an opportunity to really upgrade some of what we do as well as put in a cogeneration plant there. And so that's a flagship plant for us when we think about global texture solutions. And so it just made sense to invest in Endy. That project has already started in 2024, continues in 2025, it'll wrap up in 2026. And so I think as we noted, we're going to call this out for investors as what we call cost savings and infrastructure.

We're going to call it in its own bucket. And we'll talk a little bit more about the expected returns, but we believe that this is kind of at least 10 to mid teens IRR type of opportunity for us to deploy capital.

Yes. I think the strength of the balance sheet and the cash generation over the last couple of years gives us confidence to make these kind of investments in the business that we're confident are right in line with our strategy given the importance that that Indianapolis plant, for example, plays. But as evidenced by the share repurchases coming in more than two times what we originally targeted, we feel very confident that we've got the flexibility, balance sheet flexibility to also pursue M and A, which obviously we have a pipeline that we're always continuing to assess. So it doesn't in any way preclude us from pursuing inorganic investments as well.

Thank you. One moment for the next question. And our next question will be coming from the line of Josh Spector of UBS. Your line is open.

Yes. Hi, good morning. I wanted to ask just on the guidance framework. It seems to be if you go through the negative pricing and FX that you're assuming that volumes are up maybe mid single digit percent at your midpoint of expectations. And my reaction is pretty a healthy target if that's the right interpretation.

So can you give us some context about what gives you confidence in that? Is that new wins? Are there specific markets? Really what's driving that overall?

Yes. Maybe to clarify, Josh, I mean, I would say that our sales volume expectation for Textron Health Solutions is in that mid single digits. And I would probably say that the F and I businesses have a lower sales volume target than that. We are seeing those significantly less price mix. So maybe I'm catching in your assumption that there's still some significant you may have in your assumptions or how you work through it kind of a greater price mix headwind.

We see that dampening and much less in 2025 versus what we've experienced in 2024.

Yes. I guess let me step back and try that again. I thought at an overall level you're guiding towards low single digit revenue growth. That's net of pricing, that's net of negative FX. If I say each of those are a point, I mean, maybe I'm differentiating between five versus three.

Yes. And that's yes. So I would say there's still again, we're looking at probably total company, low single digit to between low single digit and mid single digit volume, slight price mix and foreign exchange is maybe not as much as you assume when we look at the total revenue mix right now.

Okay, understood. Let me move on to another one quickly to ask just on the contract structure of what you have in place with the multiyear contracts. I think you said earlier you'll give maybe some more detail update later in the year, but can you just give us a state of the union on where we stand now in terms of how many of the contracts are on a multiyear basis, how much we need to think about coming off over the next couple of years and your visibility to being able to address some of that effectively?

Yes. Let me just take a question in totality from a standpoint of, I guess, how do we feel coming out of contracting? I would say that in general, we're pleased with the results of contracting. And we expect operating income margins for Texture and Healthful Solutions, Food and Industrial Ingredients LatAm and our businesses that are in the other category to demonstrate margin expansion. The margin expansion is going to be supported by price management and our corn procurement and hedging practices as we move through dynamic environment.

For the Food and Industrial Ingredients U. S./Canada business, we are expecting to hold operating income margin for this segment as we have achieved significant operating margin expansion over the last two years in the range of seven. So just holding that margin, we think is a great achievement. And the segment operating improvements will be part of it in his remarks by an increase in corporate costs as we invest in some digital transformation investments as well as R and D. And

the company, we anticipate operating income margin improvement to be in the range of 30 to 70 basis points. That's inclusive of those investments in operating incomes operating income corporate costs, I should say. The issue around multiyear contracts, I think the majority of those adjustments took place last year. So there's not any significant multi year adjustments heading into 2025. There'll be one or two here and there, but not of the order of magnitude because typically when these contracts renew, they're multi year contracts.

So again, being able in The U. S, Canada Food And Industrial Ingredients business to be able to hold that 700 to 800 basis points increase over the last year or two is quite a significant achievement that I think

highlights the strength of the business model in that business.

The contracting is complete and the way that manifests in our business, Josh, is that we take all of those contracts and as we put them into the system, we come up with kind of that weighted average change relative to when we locked in the underlying raw material with the customer for their volume commitment for 2025, run that and then what you get from us is a perspective which Jim highlighted on our operating income margin expansion or stability.

Yes. And just to put a finer point to make sure there's no confusion, so there really is nothing materially outstanding in relationship to contracting. Contracting is complete and that is the case in The U. S. And that is the case in Europe and pretty much around the world.

Thank you. One moment for the next question. And our next question will be coming from the line of Andrew Sticek of BMO Capital Markets. Your line is open.

Hey, good morning. Thanks for taking the questions. My first one, I wanted to go back to the texture and helpful solutions guidance. And at the recent Innovation Day, I think you gave a profit growth algo that was at 8% to 10% and recognizing you're giving a range for the guidance for this year, the low end of that obviously leaves room for some shortfall relative to that algo. So I know you talked about FX.

Is there anything else on the downside on the lower end of that that could be pressuring that below the algo? And then I guess the follow on to that would be as we get beyond 25%, are you assuming then that you grow kind of towards the higher end of that outlook and what drives that reacceleration?

Your answer to your latter question is yes. And I think just on the range for Textron Health Solutions is just being cautious a little bit about the strength of the dollar, kind of strength of some of the countries' economies where we primarily are really growing Textron Health also. So Southeast Asia, looking at China and looking at parts of Europe and as well as The Middle East, We're still very optimistic to think about the strength of this business and just want to make sure that we still play through kind of how the strength of the dollar looks relative to some currencies.

Got it. Okay. Okay. And I know that the guidance doesn't really contemplate some of the outside potential factors around tariffs and trade and food ingredient regulations. I guess I'm just curious from your perspective, how you weigh those risks and the positioning of the portfolio, particularly as it relates to kind of scrutiny for the helpfulness of the food supply chain and where you might be positioned like do you think about demand shifts within your portfolio where that could be a net benefit?

Do you see those as potential headwinds? I guess when you think about these things in their totality, should they come to pass how you weigh the portfolio's positioning? Thanks.

Yes. Let Jim and I tag team on this one. So first of all, as mentioned, I think during our prepared remarks, the 2025 outlook does not consider extraordinary changes to current tax rates, to tariffs or trade or food regulations. Ingredion, of course, we're monitoring any new announcements by the administration or any of the trading partners with The U. S.

To assess any potential impacts of city tariffs. With respect to The U. S, Mexico and Canada trade relationships, I think it is important though to highlight something that we've talked about in the past about our business and that is that we have local manufacturing in each country. So for example, we're the only corn wet miller in Canada with two manufacturing facilities and in Mexico with three manufacturing facilities that supply predominantly a local customer base. We source corn locally in each country, although we do rely on corn imports from The U.

S. Into Mexico. So that's one of the things that obviously we'll be watching. And this is a very dynamic situation right now and we're committed to sharing any relevant updates to the full year outlook as we gain more clarity. And once we have some certainty around the impact on scope and timing of any potential tariffs.

At the same time, we're doing scenario planning, as you would expect to review our regional supply chain operations throughout LatAm, The U. S. And Canada to look at alternative sourcing paths should they arise, as you would expect. Jim, do you want to add to this?

No, Andrew, and I think to everybody listening, right? Timing always helps, right? If it's clear that there is going to be an amount of a tariff and when just supply chains like to move and they like to have time to be able to move. It allows us to think about our input costs. It thinks about where we are going to manufacture, how we approach customers in terms of what might be additional costs that we then have to pass through on pricing as well as what's the impact of our customers business to tariffs.

So just it allows us all to kind of think through each one of those in lockstep and then come to, I think, a pretty good assessment in terms of whether there's opportunities or risks to the business.

Thank you. One moment for the next question. And our next question will be coming from the line of Param Shama of Stephens. Your line is open.

Thank you. Just wanted to ask about the cost to compete program. I know you achieved a good run rate thus far, but was just wondering if you could provide a little bit more granularity in terms of specific cost levers that you thought had the most impact so far. And I believe you mentioned this, but if you could just talk about the biggest opportunities that you see in 2025 for cost to compete?

Sure. So just a reminder that we had set a target for the first year of the program. Typically when you're ramping up activities along such a program that is enterprise wide, we had set a target, we delivered more than $23,000,000 which was greater than 30% of what we had originally targeted in the year. So we built momentum throughout. But one of the levers that obviously was pulled was consistent with our play to win strategy refresh and the reorganization and re segmentation.

And that obviously afforded us an opportunity to look across the entire organization and what winning skills and differentiating capabilities we needed to have to execute the strategy. And so a number of people within our organization were reassigned to different roles. And then at the same time, that led to opportunities to streamline the organization. And so what was great about the program coming up on the heels of completing a 2023 enterprise wide strategy refresh is the ability to align our cost structure to our strategy and with people being on the right seat, right? From getting into the second year, what we're very excited about and what we mentioned in the remarks are network and looked at opportunities for these product flows and capacity utilizations across our network most efficiently and that led to the decision to shutter three facilities.

Now they're smaller facilities, but some involve some investment in other plants to compensate. But from a standpoint of driving efficiency, modernization and overall maximizing capital maximizing capacity utilization, that's where the second year for the most part of cost to compete savings are going to come from. Jim? Yes.

Well, and I just say that look, the work led by our Senior VP and Chief Supply Chain Officer, Eric Seipp and what Jim mentioned is looking at all of our manufacturing sites. The team has been looking at these for several years now. We have a different perspective. We've built a different set of capabilities. So we really can anticipate demand, where it's going to show up in the world and then work towards what's the best way to really optimize our cost of production and our cost to move product.

The only other thing I'd add is that, look, cost to compete is around expenses. But as Jim mentioned, as we get into these changes in manufacturing network, it also helps us achieve higher ROIC and a better return on our invested capital. And that's obviously as an asset intensive company, that's what we're always striving to do.

Great. I appreciate the color. Just on my follow-up, wanted to see if you could help me understand kind of how to frame up net corn costs for the year. I know you do hedge a good chunk of your corn and your co product values. But just thinking about the unhedged portion, we've seen some recent crop price rallies, some drought concerns out of South America.

Ingredion (INGR) Q4 2024 Earnings Call Transcript

Company Participants